Aspire Biopharma Holdings, Inc. Common Stock (ASBP) is a publicly traded Healthcare sector company. As of July 21, 2026, ASBP trades at $7.19 with a market cap of $8.08M and a P/E ratio of 0.00. ASBP moved +5.09% today. Year to date, ASBP is -96.14%; over the trailing twelve months it is -98.47%. Its 52-week range spans $3.31 to $11,832.00. Rallies surfaces ASBP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks ASBP insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $7.19 |
| Market Cap | $8.08M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.16% |
| 52-Week High | $11,832.00 |
| 52-Week Low | $3.31 |
| Volume | 71.47K |
| Avg Volume | 0 |
| Revenue (TTM) | $6.20K |
| Net Income | $-24.48M |
| Gross Margin | 0.00% |
ASBP analyst coverage data. Average price target: $0.00.